Exploring the Groundbreaking Benefits of Blue Light Cystoscopy in Bladder Cancer Treatment
Introducing Blue Light Cystoscopy in Bladder Cancer Management
The recent presentations at the 2025 European Association of Urology (EAU) congress in Madrid have brought to light the transformative role of Blue Light Cystoscopy (BLC) in the management of bladder cancer. Photocure ASA, known as the Bladder Cancer Company, presented two compelling abstracts demonstrating how BLC not only enhances cancer detection but also significantly reduces the risk of recurrence for patients.
The EAU 2025 Congress: A Platform for Advancement
Held from March 21 to 24, 2025, the EAU congress served as a hub for urologists worldwide, showcasing cutting-edge clinical advancements in urological care. Photocure's participation, particularly with its product Hexvix®, focused on the slogan
Topics Other）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.